Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2012
11/28/2012CN102793712A Application of chrysin in preparation of medicaments for treating autoimmune and inflammatory diseases
11/28/2012CN102793693A Applications of vorinostat in aspect of drugs for treating autoimmune diseases and inflammatory diseases
11/28/2012CN102793690A Application of juglone to preparation of medicament for treating autoimmune and inflammatory diseases
11/28/2012CN102793674A Triptolide solid lipid nanoparticle as well as preparation method and application thereof
11/28/2012CN102319371B Chinese medicinal composition for treating urinary system calculi
11/28/2012CN102319228B Dutasteride liquid hard capsule and preparation method thereof
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN102002045B Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
11/28/2012CN101978982B Application of Japanese ginseng or extract thereof to preparation of medicament for resisting gout and repairing hyperuricemic kidney injury
11/28/2012CN101917990B Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/28/2012CN101559144B Oral Tonglin Hushen capsule for curing urethritis, cystitis, acute pyelonephritis and chronic pyelonephritis and preparation method thereof
11/28/2012CN101331134B Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/27/2012US8318722 Pyrazinooxazepine derivatives
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/22/2012WO2012159107A1 Inhibition of renal fibrosis
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012100228A3 Methods and compositions for treating kidney disorders
11/22/2012WO2012098560A3 Process for the preparation of muscarinic receptor antagonist
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120295985 Methods for improving blood glucose control
11/22/2012US20120295925 Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295896 Oxadiazole inhibitors of leukotriene production
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295848 Sustained-release composition and process for producing the same
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120294946 Modulator
11/22/2012US20120294930 Combination of kinase inhibitors and uses thereof
11/22/2012US20120294928 Method of treating scars and b-catenin-mediated disorders using nefopam compounds
11/22/2012US20120294905 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
11/22/2012US20120294834 Regeneration of, reestablishing function in and replacing microvasculature in organs and tissues
11/22/2012US20120294827 Polymer gel formulation
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/21/2012EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment
11/21/2012EP2523958A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
11/21/2012EP2523662A1 "compositions comprising amino acids for prevention and/or treatment of renal disorders"
11/21/2012EP2260833B1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
11/21/2012CN102791280A Methods for the prevention or treatment of vessel occlusion injury
11/21/2012CN102791277A Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders
11/21/2012CN102791275A Adsorption carbon, and adsorbent
11/21/2012CN102787057A Health preserving and health care wine and preparation method of health preserving and health care wine
11/21/2012CN102787056A Kidney tonifying medicinal liquor
11/21/2012CN102786517A Pyrimidine thiazole amine derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102786468A Nicotinic acid derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102784376A Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis
11/21/2012CN102784367A Traditional Chinese medicine composition for treating prostatic hyperplasia and preparation method
11/21/2012CN102784320A Preparation method of traditional Chinese medicine for treating urine color yellow turbidity type acute glomerulonephritis
11/21/2012CN102784318A Preparation method of traditional Chinese medicine for treating frequent and urgent micturition insomnia
11/21/2012CN102784293A Tablet for preventing and treating nephrotic syndrome
11/21/2012CN102784271A Traditional Chinese medicine for treating urinary obstruction
11/21/2012CN102784242A Decoction medicament for treating damp-heat type proteinuria
11/21/2012CN102784237A Medicinal composition for preventing and treating diabetic complications
11/21/2012CN102784197A Lysimachia medicinal liquor
11/21/2012CN102784178A Turpinia montana leaf general flavone ethanol reflux extractive, preparation method and application thereof
11/21/2012CN102784177A Turpinia montana leaf ethanol reflux extractive, preparation method and application thereof
11/21/2012CN102319275B Sunset abelmoschus flower extract, preparation and preparation method thereof
11/21/2012CN102274400B Dry jewel orchid and processing method thereof
11/21/2012CN102138900B Solid preparation of oxapium iodide liposome
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/21/2012CN101977615B Inhibitor for blood phosphorus level elevation
11/21/2012CN101965187B Crystalline micropowder particles
11/21/2012CN101897675B Solid oral medicinal composition containing valsartan or pharmaceutically acceptable salts of valsartan
11/21/2012CN101890037B Nuezhenoside and hyperin composition and application thereof for preparing medicine
11/21/2012CN101856471B Chinese medicinal composition for tonifying kidney and strengthening body
11/21/2012CN101618105B Medicated wine for treating cystitis
11/20/2012US8314088 Pyrazinooxazepine derivatives
11/20/2012CA2529878C Pyrazole derivative, drug composition containing the same and production intermediate therefor
11/15/2012WO2012154893A1 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154892A1 Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154779A1 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154778A1 Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154776A1 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154774A1 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154771A1 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154770A1 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154249A1 Substituted aminobutyric derivatives as neprilysin inhibitors
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289568 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289567 Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289566 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289565 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289564 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289563 Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289562 Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289561 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289560 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289554 4-dimethylaminobutyric acid derivatives
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289547 Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289544 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289543 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289539 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289531 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289530 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 562